H1N1 Cases Still Increasing In Many Countries; WHO To Begin Shipping Donated Vaccines Within Weeks

With many countries continuing to report a growing number of H1N1 (hogs flu) cases, Keiji Fukuda, special adviser to the WHO monitor general on pandemic influenza, reported Thursday it was overmuch in season to declare the pandemic extremely, the Washington Post reports. “Fukuda said that season the approve wave of infections has peaked in the United States and some other countries in the Northern Hemisphere, the level of flu activity remains high elsewhere – in some European countries, including Switzerland and the Czech Republic, and in intelligence of Central Asia, like as Kazakhstan,” according to the journal.

“The pandemic is a global event. It is not of itself a regional event,” Fukuda said for the period of a briefing (Stein, 12/18). “Fukuda also noted that the signs of a top and a decrease in the caseload in North America and quarters of Europe had occurred ‘extraordinarily early for influenza,’ with several months of the winter left,” Agence France-Presse reports. “As a result, the WHO could not rule out the potentiality of any other wave of illness in late winter or early spring” (12/17).

Also for the period of the briefing, Fukuda announced the WHO’s plans to begin shipping H1N1 vaccines to Azerbaijan, Afghanistan and Mongolia within the next few weeks, the Associated Press reports. Vaccines will go to 35 developing countries soon after, the news office reports. “The U.N. health action has prioritized sending the shots to boreal half-globe countries elementary, that are being hit harder by swine flu than countries in the south half-sphere.” The article adds minor circumstances encircling individual conditions countries had to encounter in regulate to receive the vaccine donations from WHO (12/17).

The 180 the great body of the people doses of the H1N1 vaccine the WHO promised to developing countries “have been pledged by the five major manufacturers and 12 countries, although it is not unblemished in what condition frequent have followed from one side. The United States, for example, has pledged 10% of its give to the WHO but has not yet shipped any,” the Los Angeles Times reports. “But more vaccine may be appropriate to beneficial soon since many countries placed orders on the assumption that two doses would be required to immunize most people,” the newspaper continues. “Now that it is clear that one dose is fit with regard to everyone except children younger than 10, there is likely to be a surplus. The U.S., in favor of example, ordered the ingredients for 251 million doses, and it seems unlikely that all those will be used” (Maugh, 12/18).

In connected intelligence, Reuters reports officials in Germany and Spain are in talks with pharmaceutical companies about reducing deliveries and returning overplus supplies of the H1N1 vaccine. Both countries are besides exploring the options for deals to bestow excess H1N1 vaccine stores to other countries. “Fukuda said countries through superplus vaccine had ‘a equal in number of options’ including donating it to those who hold none, or keeping it in husband despite a later date,” the news service writes (Hirschler/Kelland, 12/17).

HHS Secretary Kathleen Seblieus said Thursday that by Friday the number of doses of H1N1 vaccine in the U.S. will transcend the 100 the public designate and urged Americans who had not yet admitted the vaccine to do so, AFP reports in a second story. “We have a betide to lessen the shock or even prevent a big third wave when flu gratify really hits, and need to fasten upon that chance; fit now,” Sebelius said (12/17).

PBS’ NewsHour features a documentary examining the philosophical knowledge and policy behind the H1N1 pandemic (Suarez, 12/14).

This denunciation was reprinted from dailyreports.kff.org through kind consent from the Henry J. Kaiser Family Foundation. You can view the unimpaired Kaiser Daily U.S. HIV/AIDS Report, sift the records and type up for email delivery at dailyreports.kff.org.

© Henry J. Kaiser Family Foundation. All rights reserved.

December 20 2009 05:26 pm | Immune System

Comments are closed.